Komori
Presentation materials for financial results5142Achilles CorporationMaterials and Chemicals

Financial Results Summary for the Fiscal Year Ending March 2026

For the fiscal year ending March 2026, sales increased as film products for the medical and electronics sectors and industrial materials performed well. Cost reductions and expense controls also contributed to substantial improvements in operating income, ordinary income and net income. For the fiscal year ending March 2027, however, the company has factored in proactive investments and the impact of external conditions, and forecasts lower profit.

Worth reading
61In focus
0–100. This measures how worthwhile something is to read, not how good or bad the company is.
Direction
Mixed performance
Direction inferred from the company’s description.
Scale
3409
¥ millions (year-on-year change in operating income)
Wording
Avoiding a definitive answer
How definitive the wording is.

Contents of this document

Presentation materials for financial resultsFiscal year ending March 202611 items taken from the company’s own explanation
Financial Results Figures (The key points of this material are explained below)
Net Sales¥81,802 million+3.4%
Operating profit¥2,972 million
Ordinary income¥3,919 million
Net income¥2,116 million+394.7%
Gross Profit Margin21.6 %
Operating profit margin3.6 %
Selling, general and administrative expenses¥14,719 million
Results for the three months of the current quarter
Net Sales
First quarter¥18,378 million
Second quarter¥20,640 million
Third quarter¥21,347 million
Fourth quarter¥21,539 million
Operating profit
First quarter¥445 million
Second quarter¥829 million
Third quarter¥1,144 million
Fourth quarter¥553 million
Ordinary income
First quarter¥757 million
Second quarter¥1,003 million
Third quarter¥1,681 million
Profit attributable to owners of parent for the quarter
First quarter¥246 million
Second quarter¥1,102 million
Third quarter¥1,043 million
Fourth quarter¥451 million
Full-year earnings forecast
Net Sales
¥82,500 million
Operating profit
¥2,200 million
Ordinary income
¥2,000 million
Profit attributable to owners of the parent
¥1,300 million
Dividend
30 Yen year-end
What the company explained in this material
Self-assessment against the planThe company's self-assessment against its own plan.
Progress exceeded the plan in the first year
Breakdown of Factors Affecting the ChangeReasons cited by the Company for the change in the figures.
Operating profit
Fiscal year ending March 2025¥-436 million
Increase in gross profit from higher sales¥2,712 million
Improvement in gross margin¥496 million
Decrease in selling, general and administrative expenses¥200 million
Fiscal year ending March 2026¥2,972 million
Assumptions Underlying the Business OutlookThe assumptions used by the company in preparing its forecast.
The company has taken into account the risk of foreign exchange rate fluctuations, increases in raw material prices and energy and logistics costs, and proactive investments in human capital management and digital transformation. Numerical assumptions: Not disclosed.
New initiatives
  • Business organization restructuring in June 2025
  • Launch of the Shoes Global Management Center (operational from 1 April 2026)
  • Full-scale operation in 2026 of facilities for the medical sector at the North American site
  • Development of the newly designed biodegradable multi-film product “ビオらいと”
  • Development of a technology for forming highly adhesive plated films on glass substrates with through-holes
  • Increased investment in human capital management, digital transformation, information security and governance in fiscal 2026
Key KPIsA metric the company considers important as a management benchmark.
  • Overseas revenue
    FY2024172
    FY2025214
  • Equity ratio
    Fiscal year ending March 202549.5
    Fiscal year ending March 202651.8
    Year-on-year change (points)2.3
  • ROE
    FY20241.1
    FY20255.1
    Year-on-year change (points)4
Segment results
Business Division 1
Profit
Fiscal year ending March 2025¥1,002 million
Fiscal year ending March 2026¥3,287 million
Year-on-year change in amount2,285
Business Division 2
Profit
Fiscal year ending March 2025¥-972 million
Fiscal year ending March 2026¥-321 million
Year-on-year change in amount651
Shoes BU
Profit
Fiscal year ending March 2025¥-972 million
Fiscal year ending March 2026¥-321 million
Year-on-year change in amount651
Medium-term management plan targets
FY2027
Net Sales¥88 billion
Operating profit¥3 billion
Operating profit margin3.4％
ROE5.0% or more
Fiscal 2030 outlook
Net SalesApproximately ¥100 billion
Operating profitApproximately ¥5 billion
Operating profit marginAround 5.0%
ROEAt least 7.0%
Comparison with actual resultsFiscal 2025 results are progressing ahead of plan
Financial targets
ROE
FY2025 actual5.1%
Fiscal 2027 plan5.0% or more
Fiscal 2030 outlookAt least 7.0%
Equity ratio
Actual results for the fiscal year ending March 202651.8%
Annual Dividend
Fiscal year ending March 202640 Yen all year-end dividends
Forecast for the fiscal year ending March 202730 Yen all year-end dividends
Payout ratio
Fiscal year ending March 202625.8 %
Policy30% or more
Acquisition of treasury shares
The company will act flexibly while taking into account consolidated results, growth investments and share price conditions. The amount, number of shares and period of the acquisition framework are Not disclosed.
Contents of this document
ItemDetails
Document typePresentation materials for financial results
Fiscal Period CoveredFiscal year ending March 2026
Net Sales¥81,802 million (YoY +3.4%)
Operating profit¥2,972 million
Ordinary income¥3,919 million
Net income¥2,116 million (YoY +394.7%)
Gross Profit Margin21.6 %
Operating profit margin3.6 %
Selling, general and administrative expenses¥14,719 million
Results for the three months of the current quarterNet Sales First quarter ¥18,378 million / Second quarter ¥20,640 million / Third quarter ¥21,347 million / Fourth quarter ¥21,539 million / Operating profit First quarter ¥445 million / Second quarter ¥829 million / Third quarter ¥1,144 million / Fourth quarter ¥553 million / Ordinary income First quarter ¥757 million / Second quarter ¥1,003 million / Third quarter ¥1,681 million / Fourth quarter Not disclosed / Profit attributable to owners of parent for the quarter First quarter ¥246 million / Second quarter ¥1,102 million / Third quarter ¥1,043 million / Fourth quarter ¥451 million
Full-year earnings forecastNet Sales ¥82,500 million / Operating profit ¥2,200 million / Ordinary income ¥2,000 million / Profit attributable to owners of the parent ¥1,300 million / Dividend 30 Yen (year-end)
Self-assessment against the planProgress exceeded the plan in the first year
Segment resultsBusiness Division 1 Profit Fiscal year ending March 2025 ¥1,002 million / Fiscal year ending March 2026 ¥3,287 million / Year-on-year change in amount 2,285 / Business Division 2 Profit Fiscal year ending March 2025 ¥-972 million / Fiscal year ending March 2026 ¥-321 million / Year-on-year change in amount 651 / Shoes BU Profit Fiscal year ending March 2025 ¥-972 million / Fiscal year ending March 2026 ¥-321 million / Year-on-year change in amount 651
Breakdown of Factors Affecting the ChangeOperating profit Fiscal year ending March 2025 ¥-436 million / Increase in gross profit from higher sales ¥2,712 million / Improvement in gross margin ¥496 million / Decrease in selling, general and administrative expenses ¥200 million / Fiscal year ending March 2026 ¥2,972 million
Key KPIsIndicator name Overseas revenue / FY2024 172 Hundreds of millions of yen / FY2025 214 Hundreds of millions of yen / Year on year against the same period last year Not disclosed, Indicator name Equity ratio / Fiscal year ending March 2025 49.5 % / Fiscal year ending March 2026 51.8 % / Year-on-year change (points) 2.3 %, Indicator name ROE / FY2024 1.1 % / FY2025 5.1 % / Year-on-year change (points) 4 %
Assumptions Underlying the Business OutlookThe company has taken into account the risk of foreign exchange rate fluctuations, increases in raw material prices and energy and logistics costs, and proactive investments in human capital management and digital transformation. Numerical assumptions: Not disclosed.
Medium-term management plan targetsFY2027 Net Sales ¥88 billion / Operating profit ¥3 billion / Operating profit margin 3.4％ / ROE 5.0% or more / Fiscal 2030 outlook Net Sales Approximately ¥100 billion / Operating profit Approximately ¥5 billion / Operating profit margin Around 5.0% / ROE At least 7.0% / Comparison with actual results Fiscal 2025 results are progressing ahead of plan
Financial targetsROE FY2025 actual 5.1% / Fiscal 2027 plan 5.0% or more / Fiscal 2030 outlook At least 7.0% / Equity ratio Actual results for the fiscal year ending March 2026 51.8%
Annual DividendFiscal year ending March 2026 40 Yen (all year-end dividends) / Forecast for the fiscal year ending March 2027 30 Yen (all year-end dividends)
Payout ratioFiscal year ending March 2026 25.8 % / Policy 30% or more
Acquisition of treasury sharesThe company will act flexibly while taking into account consolidated results, growth investments and share price conditions. The amount, number of shares and period of the acquisition framework are Not disclosed.
New initiativesBusiness organization restructuring in June 2025, Launch of the Shoes Global Management Center (operational from 1 April 2026), Full-scale operation in 2026 of facilities for the medical sector at the North American site, Development of the newly designed biodegradable multi-film product “ビオらいと”, Development of a technology for forming highly adhesive plated films on glass substrates with through-holes, Increased investment in human capital management, digital transformation, information security and governance in fiscal 2026
Items this document does not state (9)
Progress against full-year forecastUnit price and quantity metricsNumber of stores and locationsNumber of employeesRisk amount incorporated into the outlookCapital expendituresOrders received and order backlogMarket Size / ShareKey points of the Q&A

These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.

The reasons the company gives

The company's own explanation, not something inferred from the numbers.

For the fiscal year ending March 2026, the increase in sales and profit was attributable to strong performance in films for the medical and electronics sectors and materials for semiconductor wafer transport and manufacturing processes, as well as efforts to reduce costs and control expenses. For the fiscal year ending March 2027, the company has taken into account proactive investments in human capital management and digital transformation, along with the risk of fluctuations in foreign exchange rates. The impact of escalating tensions in the Middle East has not been included in the forecast because it is difficult to calculate it reasonably.

How to read this page

This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.
Financial Results Summary for the Fiscal Year Ending March 2026 | Achilles Corporation (5142) timely disclosure | Komori